Results 91 to 100 of about 13,490 (218)
Perampanel as add‐on in high‐grade glioma–related epilepsy: Seizure control and QoL in a prospective, multicenter, real‐world 6‐month follow‐up study
Epilepsia Open, EarlyView.Abstract Objective
High‐grade astrocytomas, including glioblastomas, are aggressive brain tumors with poor prognosis and a 5‐year survival below 7%. Seizures affect up to 75% of glioma patients, especially in low‐grade tumors but also in high‐grade cases.Matteo Impellizzeri, Paolo Paone, Giada Pauletto, Annacarmen Nilo, Simone Beretta, Andrea Salmaggi, Stefano Consoli, Stefano Quadri +7 morewiley +1 more sourcePersonalized Precision in Healthcare Payment Systems: Insights From a Real‐World Cancer Patients Cohort Study
Health Care Science, EarlyView.We developed an effective prediction model for reasonably high hospitalization costs, using gastric cancer surgery patients as an example. Integrating this assessment into the healthcare payment system based on diagnosis‐related groups is expected to improve the individualization and precision of health insurance fund utilization.Kan Xue, Hongrui Tian, Qi Wang, Yinkui Wang, Fei Shan, Yansui Yang, Miao Yu, Zhonghu He, Ziyu Li, Jiafu Ji +9 morewiley +1 more sourceHealth System Factors in Head and Neck Cancer Diagnosis: A HEADSpAcE Consortium Qualitative Study in Glasgow and Montevideo
Head &Neck, EarlyView.ABSTRACT Background
Head and neck cancer (HNC) is a devastating diagnosis, with advanced‐stage disease leading to poorer outcomes. This qualitative study aimed to identify health system factors associated with stage of HNC diagnosis. Methods
Qualitative semistructured interviews with HNC patients and clinicians were undertaken in two purposively ...Grant Creaney, Iván Lyra González, Mauricio Cuello, Mariél de Aquino Goulart, Alex D. McMahon, Claire Paterson, James McCaul, Maja Popovic, Lorenzo Richiardi, Silvia Lopez de Blanc, Maria Paula Curado, Marta Vilensky, HEADSpAcE Consortium, Elmira Ebrahimi, Apiwat Sangphukieo, Hanla A Park, Valerie Gaborieau, Wolfgang Ahrens, Laia Alemany, Lidia MRB Arantes, Jaroslav Betka, Cristina Canova, David I Conway, Mauricio Cuello, Maria Paula Curado, Ana Carolina de Carvalho, Jose Carlos de Oliviera, Mark Gormley, Maryam Hadji, Claire M Healy, Ivana Holcatova, Luis P Kowalski, Pagona Lagiou, Areti Lagiou, Gary J Macfarlane, Sandra Perdomo, Luis Felipe Ribiero Pinto, Jose Roberto V Podesta, Jerry Polesel, Miranda Pring, Hamideh Rashidian, Ricardo R Gama, Lorenzo Richiardi, Max Robinson, Paula A Rodriguez‐Urrego, Sheila C Soares‐Lima, Nicolas Timpson, Marta Vilensky, Sandra V von Zeidler, Tim Waterboer, Kazem Zendehdel, Ariana Znaor, Paul Brennan, James McKay, Shama Virani, Tom Dudding, Roque Adam, Antonio Agudo, Shaymaa F AlWaheidi, Miquel Angel Pavon, Namrah Anwar, Paola Engelmann Arantes, Lisa Arguello, Yubelly Avello, Lucas Avondet, Ana M Baldión‐Elorza, Camila Batista Daniel, Bianca Beraldi, Barbara Berenstein, Patricia Bernal, Natália Bernardino Rodrigues, Josipa Bilic Zimmermann, Marianna G Botta, Jesús Brenes, Nicole Brenner, Carol Brentisci, Catalina Burtica, María L Cabañas, Erick Cantor, Raiany S Carvalho, Andre L Carvalho, Luigi Chiusa, Priscilia Chopard, Qurratulain Chundriger, Omar Clavero, Isabela Costa, Grant Creaney, Cecilia Cuffini, Tauana C Dias, Evandro Duccini de Souza, Lais C Durant, Alberto Escallón, Gisele Aparecida Fernandes, Béatrice Fervers, Valentina Fiano, Frederico Firme Figueira, Regina Furbino Villefort, Manuela Gangemi, Paolo Garzino‐Demo, Mahin Gholipour, Raul Giglio, Mariel A Goulart, Jéssica Graça Sant'Anna, Marek Grega, Anna Clara Gregório Có, Arnau Guasch, Jose A Hakim, David N Hayes, Marco Homero de Sá Santos, Katrina Hurley, Magalí Insfran, Giuseppe C Iorio, Moghira Iqbaluddin Siddiqui, Jannik Johannsen, Martin Kaňa, Jens Peter Klussmann, Evelio Legal, Jeferson Lenzi, Fernando Luiz Dias, Iván Lyra González, Willene Machado Zorzaneli, Ricardo Mai Rocha, Manel Mañós, Priscila Marinho de Abreu, Maryam Marzban, James McCaul, Alex D. McMahon, Carlos Mena, Elismauro F Mendonça, Laura Mendoza, Lorena Meza, Birgitta Michels, Matinair S Mineiro, Chiara Moccia, Pamela Mongelos, Ana L Montealegre‐Páez, Francisca Morey Cortes, Alvaro Muñoz, Andy Ness, Aline B Neves, Marco Oliva, José Carlos de Oliveira, Hernán Ortiz, José Ortiz, Marta Osorio, Vanessa Ospina, Oliviero Ostellino, Mauricio Palau, Claire Paterson, Sonia Paytubi Casabona, Giancarlo Pecorari, David M Pereira, Olivia Pérol, Shahid Pervez, Alicia Pomata, Maja Popovic, Alisson Poveda, Carol P Prado, Kristina M Prager, Guglielmo Ramieri, Juliana NI Rego, Rui M Reis, Helene Renard, Umberto Ricardi, Giuseppe Riva, Frederic Rodilla, Ingrid Rodriguez, María I Rodríguez, Alastair Ross, Pierre‐Eric Roux, Tazeen Saeed Ali, Pierre Saintigny, Juan J Santivañez, Cristóvam Scapultampo‐Neto, Javier Segovia, Agenor Sena, Ricardo Serrano, Shachi J Sharma, Oliver Siefer, Stephanie Smart, Bruna P Sorroche, Cinthia Sosa, Juliana Souza de Oliveira, Antonella Stura, Steven Thomas, Oscar Torres, Sara Tous, Gonzálo Ucross, Adriana Valenzuela, José Roberto Vasconcelos de Podestá, Alex Whitmarsh, Sylvia Wright, Shaymaa Alwaheidi, Paul Brennan, Shama Virani, Al Ross, David I Conway +196 morewiley +1 more source“It's the Exact Same Treatment … Except Only 5 Min Away”: A RE‐AIM Evaluation of a Speech‐Language Pathology Shared‐Care Model for Rural Patients With Head and Neck Cancer
Head &Neck, EarlyView.ABSTRACT Background
Challenges accessing post‐treatment speech‐language pathology (SLP) services can add to treatment burden for rural patients with head and neck cancer (HNC). Hence, the aim of this study was to evaluate a shared‐care SLP service designed to support local SLP access for patients with HNC, using the RE‐AIM framework.Corey Patterson, Elizabeth C. Ward, Rebecca L. Packer, Jasmine Foley, Laurelie R. Wishart, Clare L. Burns, Sally Pether, Wendy Comben +7 morewiley +1 more sourceRandomized Phase II Trial of Consolidation Pembrolizumab After Definitive Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: KCSG HN19‐09, CONPELAN Study
Head &Neck, EarlyView.ABSTRACT Background
The benefit of consolidation programmed cell death protein 1 (PD‐1) blockade after chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma (NPC) remains unclear. Methods
Patients with stages II–IVB NPC were randomized (2:1) to pembrolizumab 200 mg or placebo every 3 weeks for up to 17 cycles after chemoradiotherapy ...Sang Hoon Chun, Seyoung Seo, Jang Ho Cho, Keon‐Uk Park, Sang‐Cheol Lee, Yong Won Choi, Tak Yun, Seong Hoon Shin, Sung‐Bae Kim, Seungeun Lee, Chang Ho Ahn, Bhumsuk Keam +11 morewiley +1 more sourceVisualization of Scattered Tumor Regression Following Neoadjuvant Chemoimmunotherapy With a Novel Intraoperative PET/CT Scanner
Head &Neck, EarlyView.ABSTRACT Background
Neoadjuvant chemoimmunotherapy is being explored in locally advanced head and neck squamous cell carcinoma (HNSCC), yet the spatial patterns of pathologic response and clinical implications remain poorly characterized. Methods
A 79‐year‐old female with recurrent left oral tongue SCC (PD‐L122C3 Combined Positive Score 90) who ...Andreja Radevic, Joaquin Austerlitz, Ashtyn McAdoo, Kyrionna Golliday, Takeshi Takahashi, Mitra Mehrad, Adam J. Rosenberg, Barbara A. Murphy, Eben Rosenthal, Michael C. Topf +9 morewiley +1 more source